AU
UK
CA
NZ
IND
US
Last update at 2026-06-05T20:00:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
ASX Opportunities: Aroa Biosurgery And 2 Other Promising Penny Stocks
Sun 08 Feb 26, 08:02 PM3 ASX Penny Stocks With Market Caps Under A$400M To Watch
Tue 29 Jul 25, 08:02 PM| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -1321.90000M | 32.00M | -43.90000M | -84.30000M | -20.00000M |
| Minority interest | -8.90000M | 4.30M | 15.30M | 3.90M | 2.90M |
| Net income | -1354.10000M | 27.20M | -48.80000M | -91.70000M | -21.50000M |
| Selling general administrative | 428.10M | 262.40M | 198.70M | 121.20M | 65.50M |
| Selling and marketing expenses | 1379.70M | - | - | - | - |
| Gross profit | 595.20M | 349.00M | 199.50M | 78.60M | 63.50M |
| Reconciled depreciation | 35.20M | 26.60M | 14.50M | 5.80M | 1.60M |
| Ebit | -1252.90000M | 64.40M | -28.80000M | -80.10000M | -17.10000M |
| Ebitda | -1217.70000M | 91.00M | -14.30000M | -74.30000M | -15.50000M |
| Depreciation and amortization | 35.20M | 26.60M | 14.50M | 5.80M | 1.60M |
| Non operating income net other | - | - | - | - | - |
| Operating income | -1321.90000M | 32.00M | -43.90000M | -84.30000M | -20.00000M |
| Other operating expenses | 2201.40M | 565.70M | 373.60M | 297.40M | 123.20M |
| Interest expense | 69.00M | 32.40M | 15.10M | 4.20M | 2.90M |
| Tax provision | 23.30M | 9.10M | 20.20M | 11.30M | 4.30M |
| Interest income | 79.00M | 37.20M | 16.70M | 2.00M | 0.20M |
| Net interest income | -69.00000M | -19.10000M | -10.90000M | -4.20000M | -2.90000M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 23.30M | 9.10M | 20.20M | 11.30M | 4.30M |
| Total revenue | 879.50M | 597.70M | 329.70M | 213.10M | 103.20M |
| Total operating expenses | 1917.10M | 317.00M | 243.40M | 162.90M | 83.50M |
| Cost of revenue | 284.30M | 248.70M | 130.20M | 134.50M | 39.70M |
| Total other income expense net | 20.00M | -19.10000M | -10.90000M | -4.20000M | -2.90000M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | -1345.20000M | 23.14M | -64.10000M | -95.60000M | -24.30000M |
| Net income applicable to common shares | -1425.00000M | 27.20M | -48.80000M | -91.70000M | - |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 8263.10M | 6094.90M | 3737.20M | 2199.10M | 1155.50M |
| Intangible assets | 152.50M | 116.70M | 99.90M | 74.80M | 46.70M |
| Earning assets | - | - | - | - | - |
| Other current assets | -639.30000M | 231.70M | 233.80M | -1168.20000M | -635.30000M |
| Total liab | 7536.70M | 5667.90M | 3450.50M | 1849.10M | 899.40M |
| Total stockholder equity | 697.70M | 408.70M | 310.50M | 354.50M | 257.90M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | 3518.30M | 527.20M | 91.60M | -393.70000M | -242.80000M |
| Common stock | 0.00022M | 0.00000M | 0.00000M | 0.00000M | - |
| Capital stock | 0.00000M | 486.20M | 381.80M | 381.10M | 173.80M |
| Retained earnings | -1536.90000M | -182.80000M | -210.00000M | -161.20000M | -69.50000M |
| Other liab | - | - | - | - | - |
| Good will | 63.10M | 30.90M | 20.70M | 18.30M | 12.60M |
| Other assets | 4600.40M | 6094.90M | 3737.20M | 2199.10M | 1155.50M |
| Cash | 1799.30M | 1225.70M | 775.40M | 446.20M | 301.90M |
| Cash and equivalents | 1799.30M | 1273.00M | 775.40M | 446.20M | - |
| Total current liabilities | 7201.50M | 541.80M | 101.10M | - | - |
| Current deferred revenue | 2163.00M | 193.00M | 120.40M | 84.50M | 30.20M |
| Net debt | -1678.00000M | -1104.30000M | -655.10000M | -345.70000M | -252.00000M |
| Short term debt | 3.10M | 0.80M | 0.00000M | 0.00000M | - |
| Short long term debt | - | - | - | - | - |
| Short long term debt total | 121.30M | 121.40M | 120.30M | 100.50M | 49.90M |
| Other stockholder equity | 2232.40M | 124.80M | 146.20M | 145.50M | 145.50M |
| Property plant equipment | - | - | - | - | - |
| Total current assets | 3547.60M | 5251.70M | 3284.10M | - | - |
| Long term investments | 722.40M | 562.50M | 226.90M | 260.50M | 146.90M |
| Net tangible assets | - | - | - | - | - |
| Short term investments | 712.00M | 64.80M | 8.00M | 62.80M | 38.20M |
| Net receivables | 1717.20M | 3729.50M | 2266.90M | 659.20M | 295.20M |
| Long term debt | 121.30M | 121.40M | 120.30M | 100.50M | 49.90M |
| Inventory | - | - | - | - | - |
| Accounts payable | 1517.10M | 13.80M | 9.50M | 277.40M | 192.20M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | 2.20M | -19.50000M | -7.50000M | -10.90000M | 8.10M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | -194.90000M | 157.50M | 93.00M | -353.60000M | -206.20000M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 115.10M | 843.20M | 453.10M | - | - |
| Capital lease obligations | - | - | - | - | - |
| Long term debt total | 121.30M | 121.40M | 120.30M | 100.50M | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | -121.30000M | -380.10000M | -11.70000M | -147.50000M | -132.50000M |
| Change to liabilities | - | - | - | - | - |
| Total cashflows from investing activities | -175.70000M | -380.10000M | -11.70000M | -147.50000M | -132.50000M |
| Net borrowings | -0.80000M | -0.70000M | 18.00M | 51.30M | 49.50M |
| Total cash from financing activities | 207.90M | 110.30M | 10.30M | 254.70M | 233.70M |
| Change to operating activities | - | - | - | - | - |
| Net income | -1345.20000M | 22.40M | -64.10000M | -96.40000M | -24.40000M |
| Change in cash | 526.30M | 497.40M | 291.80M | 158.30M | 216.10M |
| Begin period cash flow | 1273.00M | 775.80M | 484.00M | 325.70M | 85.80M |
| End period cash flow | 1799.30M | 1273.20M | 775.80M | 484.00M | 301.90M |
| Total cash from operating activities | 445.10M | 785.50M | 289.90M | 65.70M | 112.70M |
| Issuance of capital stock | 392.00M | 114.50M | 0.70M | 204.80M | 184.20M |
| Depreciation | 35.20M | 26.60M | 14.50M | 5.80M | 1.60M |
| Other cashflows from investing activities | -168.10000M | -1.30000M | -0.10000M | 0.60M | -0.10000M |
| Dividends paid | - | - | - | - | - |
| Change to inventory | - | - | - | - | - |
| Change to account receivables | -1067.20000M | -782.50000M | -636.70000M | -370.10000M | -181.90000M |
| Sale purchase of stock | -175.30000M | 114.50M | 0.70M | 204.80M | - |
| Other cashflows from financing activities | -183.30000M | 111.00M | -7.70000M | 203.40M | 153.30M |
| Change to netincome | - | - | - | - | - |
| Capital expenditures | 41.40M | 34.40M | 32.60M | 26.70M | 14.70M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | 397.80M | 801.10M | 356.50M | 157.90M | 127.70M |
| Stock based compensation | 43.10M | 8.40M | 4.80M | 0.00000M | - |
| Other non cash items | 1346.20M | -32.10000M | -22.10000M | 4.20M | 9.50M |
| Free cash flow | 403.70M | 751.10M | 257.30M | 39.00M | 98.00M |
Sector: Financial Services Industry: Insurance Brokers
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | |
|---|---|---|---|---|---|---|---|---|
| ARX Accelerant Holdings |
0.24 1.63% | 14.99 | - | 25.64 | 3.86 | 4.73 | 1.85 | |
| AON Aon PLC |
6.29 1.95% | 328.53 | 19.50 | 17.61 | 4.19 | 7.68 | 4.95 | 13.01 |
| AJG Arthur J Gallagher & Co |
5.14 2.44% | 216.14 | 38.90 | 16.75 | 4.44 | 2.46 | 4.98 | 19.11 |
| WTW Willis Towers Watson PLC |
4.95 1.91% | 263.54 | 25.57 | 16.03 | 2.81 | 2.80 | 3.28 | 15.43 |
| BRO Brown & Brown Inc |
1.48 2.58% | 58.86 | 21.48 | 15.20 | 4.07 | 1.87 | 5.25 | 14.80 |
Accelerant Holdings, together with its subsidiaries, operates a data-driven risk exchange that connects selected specialty insurance underwriters with risk capital partners. The company operates through Exchange Services, MGA Operations, and Underwriting segments. The Exchange Services segment consists of risk exchange, its operating platform that incorporates various technology, data ingestion, and agency operations that serve the needs of its members and risk capital partners. Its Risk capital partners write premiums directly through the Risk Exchange pay us a fixed-percentage, volume-based fee for sourcing, managing, and monitoring the business they write. The MGA Operations segment includes the fees earned by members, predominantly for originating and underwriting a portfolio of insurance policies, reduced by the expenses associated with providing services. The Underwriting segment is involved in underwriting insurance policies and assumption of reinsurance policies issued or accepted by consolidated insurance and reinsurance companies. Its Underwriting segment is a strategic asset that enables access to portfolio for current and prospective risk capital partners. The activities of insurance companies include property and casualty insurance, policy issuance, and reinsurance arrangements. The company focuses on small-to-medium sized commercial clients primarily in the United States, Europe, Canada, Australia, and the United Kingdom. The company was founded in 2018 and is based in Grand Cayman, Cayman Islands.
Regatta Office Park, Grand Cayman, Cayman Islands, KY1-1108
| Name | Title | Year Born |
|---|---|---|
| Mr. Jeffrey Lee Radke | Co-Founder, CEO & Director | 1969 |
| Mr. Christopher Lee-Smith | Co-Founder, Global Head of Distribution & Director | 1969 |
| Mr. Francis James O'Neill | Co-Founder & Chief Underwriting Officer | 1974 |
| Ms. Linda S. Huber | CFO, Principal Financial & Accounting Officer | 1959 |
| Mr. Pete Horst | Chief Technology Officer | NA |
| Mr. Raymond Iardella | Head of Investor Relations | NA |
| Mr. Cliff Jenks | General Counsel & Corporate Secretary | 1979 |
| Mr. Matthew David Sternberg | Chief Operating Officer of Risk Exchange | 1987 |
| Ms. Chelsea Perkins | Chief Claims Officer | NA |
| Mr. Ryan Schiller | Head of Strategy | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Please wait processing your request...